A phase II study of high-dose celecoxib and metronomic 'low-dose' cyclophosphamide and methotrexate in patients with relapsed and refractory lymphoma

by Naser Abd El Bary, Tarek Hashem, Hasan Metwally, Ashraf Abd Ghany, Hager Abd El Mageed
Published 2010-01-01